Type-2 Diabetes: Examination of cardiovascular Risk Profile of oral Semaglutide Comment

被引：0
|
作者：
Ritzel, Robert [1 ]
机构：
[1] Stadt Klinikum Munchen, Klin Endokrinol Diabetol & Angiol, Munchen Klin Schwabing & Bogenhausen, Munich, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2019年 / 14卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [31] Oral Semaglutide (Rybelsus) for the Treatment of Type 2 Diabetes Mellitus
    Semenya, Afi Mansa
    Wilson, Stephen A.
    [J]. AMERICAN FAMILY PHYSICIAN, 2020, 102 (10) : 627 - 628
  • [32] Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes
    A. Basolo
    P. Fierabracci
    G. Salvetti
    F. Santini
    [J]. Journal of Endocrinological Investigation, 2024, 47 : 1047 - 1049
  • [33] Correction to: Response to “Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes”
    Muhammad Rafay Shahzad Cheema
    Satesh Kumar
    [J]. Acta Diabetologica, 2023, 60 : 717 - 717
  • [34] Usefulness of Empagliflozin Versus Oral Semaglutide for Prevention of Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus
    Hammerman, Ariel
    Moore, Candace Makeda
    Aboalhasan, Enis
    Azuri, Joseph
    Arbel, Ronen
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 170 : 128 - 131
  • [35] Type-2 diabetes mellitus and cardiovascular disease
    Henning, Robert J.
    [J]. FUTURE CARDIOLOGY, 2018, 14 (06) : 491 - 509
  • [36] RISK CALCULATION OF TYPE-2 DIABETES
    HAAS, T
    SVACINA, S
    PAV, J
    HOVORKA, R
    SUCHARDA, P
    SONKA, J
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1994, 41 (3-4) : 297 - 303
  • [37] Risk for the heart: Type-2 diabetes
    Julius, U
    [J]. ERNAHRUNGS-UMSCHAU, 2004, 51 (09): : 5 - 6
  • [38] Vascular ultrasound for cardiovascular risk stratification in asymptomatic patients with type-2 diabetes
    Malaha, Angeladine Kenne
    Magne, Julien
    Jarlan, Lucile
    Mansour, Katia
    Ait-Ouatet, Melissa
    Galinat, Sophie
    Teissier, Marie-Pierre
    Lacroix, Philippe
    Desormais, Ileana
    Aboyans, Victor
    [J]. PRIMARY CARE DIABETES, 2021, 15 (04) : 726 - 732
  • [39] MICROALBUMINURIA AND CARDIOVASCULAR RISK-FACTORS IN TYPE-2 DIABETES-MELLITUS
    ALLAWI, J
    JARRETT, RJ
    [J]. DIABETIC MEDICINE, 1990, 7 (02) : 115 - 118
  • [40] New practice in semaglutide on type-2 diabetes and obesity:clinical evidence and expectation
    Yalin Liu
    Xianghang Luo
    [J]. Frontiers of Medicine., 2022, 16 (01) - 24
12345